SCHEMBL1645071

SCHEMBL1645071

Cc1ncccc1-c1cc2ccccn2c1C(=O)C(=O)Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.48
THRB P10828 1/20 0.43
L3MBTL1 Q9Y468 7/20 0.41
MAPT P10636 5/20 0.41
HTT P42858 4/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
ATM Q13315 1/20 0.41
POLB P06746 1/20 0.39
KDM4E B2RXH2 4/20 0.39
RAB9A P51151 2/20 0.39
ALDH1A1 P00352 6/20 0.39
MAPK1 P28482 4/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
LMNA P02545 2/20 0.37
MKNK1 Q9BUB5 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3884093 0.86 SMN1; SMN2 (0.46) SMN1; SMN2THRBL3MBTL1MAPTHTT
SCHEMBL3886862 0.83 SMN1; SMN2 (0.50) SMN1; SMN2THRBL3MBTL1MAPTHTT
SCHEMBL2230764 0.83 SMN1; SMN2 (0.43) SMN1; SMN2THRBL3MBTL1MAPTHTT
SCHEMBL3883352 0.81 BAZ2B (0.50) SMN1; SMN2THRBL3MBTL1MAPTHTT
SCHEMBL1646968 0.79 SMN1; SMN2 (0.48) SMN1; SMN2THRBL3MBTL1MAPTHTT
SCHEMBL3886464 0.78 SMN1; SMN2 (0.56) SMN1; SMN2THRBL3MBTL1MAPTHTT
SCHEMBL3886971 0.78 SMN1; SMN2 (0.47) SMN1; SMN2THRBL3MBTL1MAPTHTT
SCHEMBL3886744 0.77 SMN1; SMN2 (0.59) SMN1; SMN2THRBL3MBTL1MAPTHTT
SCHEMBL3889228 0.77 SMN1; SMN2 (0.55) SMN1; SMN2THRBL3MBTL1MAPTHTT
SCHEMBL1645731 0.76 SMN1; SMN2 (0.68) SMN1; SMN2THRBL3MBTL1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097413-B1 2-[(2-SUBSTITUTED)-IND0LIZIN-3-YL]-2-OXO-ACETAMIDE DERIVATIVES AS ANTIFUNGAL AGENTS F2G LTD (GB) 2013-12-25 EP disclosed
EP-2303329-A1 ANTIFUNGAL COMBINATION THERAPY F2G Limited (GB) 2011-04-06 EP disclosed
WO-2009144473-A1 ANTIFUNGAL COMBINATION THERAPY F2G LIMITED (GB) 2009-12-03 WO disclosed
EP-2097413-A1 2-[(2-SUBSTITUTED)-IND0LIZIN-3-YL]-2-OXO-ACETAMIDE DERIVATIVES AS ANTIFUNGAL AGENTS F2G Limited (GB) 2009-09-09 EP disclosed
WO-2008062182-A1 2- [ (2-SUBSTITUTED) -IND0LIZIN-3-YL] -2-OXO-ACETAMIDE DERIVATIVES AS ANTIFUNGAL AGENTS F2G LTD (GB) 2008-05-29 WO disclosed